Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 Oct;124(4):1031-9.
doi: 10.1542/peds.2008-2980. Epub 2009 Sep 28.

Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use

Affiliations
Comparative Study

Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use

Michael W Kuzniewicz et al. Pediatrics. 2009 Oct.

Abstract

Objective: The goal was to assess the impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use.

Methods: In this retrospective cohort study of 358086 infants of > or =35 weeks and > or =2000 g born between January 1, 1995, and June 30, 2007, we obtained demographic data, bilirubin levels, and codes for inpatient phototherapy from existing databases. We compared the incidence of high total serum bilirubin (TSB) levels and phototherapy before and after implementation of universal screening and examined risk factors for high TSB levels.

Results: A total of 38182 infants (10.6%) were born at facilities that had implemented universal bilirubin screening. Compared with infants born at facilities that were not screening, these infants had a 62% lower incidence of TSB levels exceeding the American Academy of Pediatrics exchange guideline (0.17% vs 0.45%; P < .001), received twice the inpatient phototherapy (9.1% vs 4.2%; P < .001), and had slightly longer birth hospitalization lengths of stay (50.9 vs 48.7 hours; P < .001). Of those receiving phototherapy, 56% after initiation of universal screening had TSB levels at which phototherapy was recommended by the guideline, compared with 70% before screening. The adjusted odds ratio for developing TSB levels exceeding the guideline value was 0.28 (95% confidence interval: 0.20-0.40) for those born at a facility using TSB screening and 0.28 (95% confidence interval: 0.19-0.42) for those born at a facility using transcutaneous bilirubin screening.

Conclusions: Universal bilirubin screening was associated with a significantly lower incidence of severe hyperbilirubinemia but also with increased phototherapy use.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Temporal trends (1995–2007) in TSB testing and TSB levels of ≥25 mg/dL. TcB testing not included in figure.
FIGURE 2
FIGURE 2
Temporal trends (2004 –2007) in TSB testing according to facility.
FIGURE 3
FIGURE 3
Temporal trends (1995–2007) in phototherapy (PT) use.
FIGURE 4
FIGURE 4
Temporal trends (2004 –2007) in phototherapy use during the birth hospitalization according to facility.
FIGURE 5
FIGURE 5
Comparison of phototherapy use with the 2004 AAP guideline.

References

    1. American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316. - PubMed
    1. Bhutani VK, Johnson LH, Schwoebel A, Gennaro S. A systems approach for neonatal hyperbilirubinemia in term and near-term newborns. J Obstet Gynecol Neonatal Nurs. 2006;35(4):444–455. - PubMed
    1. Petersen JR, Okorodudu AO, Mohammad AA, Fernando A, Shattuck KE. Association of transcutaneous bilirubin testing in hospital with decreased readmission rate for hyperbilirubinemia. Clin Chem. 2005;51(3):540–544. - PubMed
    1. Eggert LD, Wiedmeier SE, Wilson J, Christensen RD. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics. 2006;117(5) Available at: www.pediatrics.org/cgi/content/full/117/5/e855. - PubMed
    1. Bhutani VK, Gourley GR, Adler S, Kreamer B, Dalin C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2000;106(2) Available at: www.pediatrics.org/cgi/content/full/106/2/e17. - PubMed

Publication types

MeSH terms